Hyaluronic gel

Hyaluronic gel is a soft-tissue filler widely used in Europe. Hyaluronic acid is a natural component of the skin, holding skin cells in place. It is widely used in cosmetic products, and a gel product has been approved in Europe. It is soon to be approved in the USA. Products include Restylane, Perlane, Hylaform. Hyaluronic gel implants persist for around a year before the filling effect begins to dwindle.

Safety data have been reported from 406,000 patients treated in 1999 and 2000, showing an incidence of 0.04 adverse events per hundred patients treated. Usual adverse events include localised hypersensitivity and injection site reactions that did not require treatment.

UniMed, the Swedish manufacturer of Restylane, is planning a Los Angeles trial of its product for the treatment of lipoatrophy.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.